Lv21
118 积分 2021-10-18 加入
Prognostic importance of concomitant non-regional lymph node and bone metastases in men with newly diagnosed metastatic prostate cancer
2小时前
待确认
Cytoreductive Radical Prostatectomy in Patients with Prostate Cancer and Low Volume Skeletal Metastases: Results of a Feasibility and Case-Control Study
1个月前
已完结
Radical cytoreductive prostatectomy in men with prostate cancer and oligometastatic disease
1个月前
已完结
Changing Nature of High Risk Patients Undergoing Radical Prostatectomy
3个月前
已完结
Updated treatment recommendations for prostate cancer from the ESMO Clinical Practice Guideline considering treatment intensification and use of novel systemic agents
3个月前
已完结
Cancer of unknown primary: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
3个月前
已完结
Androgen deprivation therapy use and duration with definitive radiotherapy for localised prostate cancer: an individual patient data meta-analysis
4个月前
已完结
Testosterone suppression plus enzalutamide versus testosterone suppression plus standard antiandrogen therapy for metastatic hormone-sensitive prostate cancer (ENZAMET): an international, open-label, randomised, phase 3 trial
4个月前
已完结
Metastatic Hormone-Sensitive Prostate Cancer and Combination Treatment Outcomes A Review
4个月前
已完结
Based on ARASENS trial: efficacy and safety of darolutamide as an emerging option of endocrinotherapy for metastatic hormone-sensitive prostate cancer-an updated systematic review and network meta-analysis
4个月前
已完结
皖公网安备34019202002308
